alexa Use of whole-genome association scans in disease gene identification, drug discovery and development.
Toxicology

Toxicology

Journal of Clinical Toxicology

Author(s): Roses AD, St Jean PL, Ehm MG

Abstract Share this page

Abstract Over the past decade, whole-genome scans have been used by academia and industry as an increasingly important tool in identifying genes of disease susceptibility. Genome coverage has improved dramatically, from sparse panels of hundreds or thousands of genetic markers five to ten years ago, to panels now comprising over 500,000 markers that capture more than 80\% of the genetic information in the genome. Whole-genome scans have played a role in drug discovery, for which knowledge of the genes and gene pathways involved in disease susceptibility can be incorporated into the selection of drug targets. Such scans also have an important role in drug development, as the pharmaceutical industry shifts from a blockbuster strategy to a niche market approach; given that not all patients will receive benefit from a particular medication, genetic markers that predict efficacy can be used to identify subgroups of patients who display a significant therapeutic response. Similarly, genetic information can be used during the drug development and postmarketing stages to predict individuals who are at risk for an adverse event. At-risk patients can receive alternative therapies, while those individuals who are not at risk, and benefit from a given medication, can continue on the treatment regimen. This feature article discusses the use of whole-genome association scans in disease gene identification, drug discovery and development.
This article was published in IDrugs and referenced in Journal of Clinical Toxicology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords